Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2Mesothelioma 1Melanoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Fecal Microbiota Transplantation × Clear all
NCT02770326 2025-04-08

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Memorial Sloan Kettering Cancer Center

Phase NA Completed
10 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT05273255 2025-03-28

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

University of Zurich

Phase NA Completed
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡